Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Induction of B7-1 in podocytes is associated with nephrotic syndrome
Jochen Reiser, … , Jordan A. Kreidberg, Peter Mundel
Jochen Reiser, … , Jordan A. Kreidberg, Peter Mundel
Published May 15, 2004
Citation Information: J Clin Invest. 2004;113(10):1390-1397. https://doi.org/10.1172/JCI20402.
View: Text | PDF
Article Nephrology Article has an altmetric score of 7

Induction of B7-1 in podocytes is associated with nephrotic syndrome

  • Text
  • PDF
Abstract

Kidney podocytes and their slit diaphragms form the final barrier to urinary protein loss. This explains why podocyte injury is typically associated with nephrotic syndrome. The present study uncovered an unanticipated novel role for costimulatory molecule B7-1 in podocytes as an inducible modifier of glomerular permselectivity. B7-1 in podocytes was found in genetic, drug-induced, immune-mediated, and bacterial toxin–induced experimental kidney diseases with nephrotic syndrome. The clinical significance of our results is underscored by the observation that podocyte expression of B7-1 correlated with the severity of human lupus nephritis. In vivo, exposure to low-dose LPS rapidly upregulates B7-1 in podocytes of WT and SCID mice, leading to nephrotic-range proteinuria. Mice lacking B7-1 are protected from LPS-induced nephrotic syndrome, suggesting a link between podocyte B7-1 expression and proteinuria. LPS signaling through toll-like receptor-4 reorganized the podocyte actin cytoskeleton in vitro, and activation of B7-1 in cultured podocytes led to reorganization of vital slit diaphragm proteins. In summary, upregulation of B7-1 in podocytes may contribute to the pathogenesis of proteinuria by disrupting the glomerular filter and provides a novel molecular target to tackle proteinuric kidney diseases. Our findings suggest a novel function for B7-1 in danger signaling by nonimmune cells.

Authors

Jochen Reiser, Gero von Gersdorff, Martin Loos, Jun Oh, Katsuhiko Asanuma, Laura Giardino, Maria Pia Rastaldi, Novella Calvaresi, Haruko Watanabe, Karin Schwarz, Christian Faul, Matthias Kretzler, Anne Davidson, Hikaru Sugimoto, Raghu Kalluri, Arlene H. Sharpe, Jordan A. Kreidberg, Peter Mundel

×

Figure 1

Options: View larger image (or click on image) Download as PowerPoint
B7-1 expression in podocytes. (A) Differential display PCR of WT (+/+) a...
B7-1 expression in podocytes. (A) Differential display PCR of WT (+/+) and α3_/_ (_/_) podocytes. The arrow indicates the position of B7-1. (B) Induction of B7-1 mRNA expression in α3_/_ podocytes. RT-PCR from three independent samples (a_c) on serial dilution (1:5 to 1:25) of cDNA standardized for β-actin. Con, H2O control. (C) Rescue (Res) of α3_/_ podocytes by stable transfection with human α3 integrin restored B7-1 expression to WT levels. RT-PCR for GAPDH shows equal RNA concentrations. (D) Dose-dependent increase of B7-1 mRNA in WT podocytes in response to puromycin (0.1, 1, 5, 10, and 50 ∝g/ml). (E) Time course of B7-1 and α3 integrin mRNA expression in puromycin aminonucleoside_treated (PAN-treated) WT podocytes. As early as 6 and 24 hours, B7-1 is induced by PAN, whereas α3 integrin levels remain unchanged. (F) B7-1 is not expressed in E18 WT kidneys (left panel) but is expressed in podocytes of α3_/_ kidneys as shown by double labeling with synaptopodin (right panels).

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Posted by 5 X users
Referenced in 3 patents
Highlighted by 1 platforms
165 readers on Mendeley
1 readers on CiteULike
See more details